Market Cap
$97.28 M
-$2.51 M-2.52%
Wed, 05 Mar 2025 21:32:23 GMT
Summary
- As of March 6, 2025, GALT market capitalization is $97.28 million, with a fall of -$2.51 million (-2.52%) during the most recent trading day.
- Over the past year, GALT market cap has dropped by -$30.24 million (-23.71%).
- GALT market cap is now -72.07% below its all-time high of $348.29 million.
Performance
GALT Market Cap Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Related metrics
Market Cap Formula
Market Cap = Price ✕ Shares Outstanding
GALT Market Cap Trends
| PeriodPeriod | Market capMarket cap | PricePrice | Shares outstandingShares outstanding | Enterprise valueEnterprise value |
|---|---|---|---|---|
| todaytoday | -2.5% | -2.5% | +0.7% | -1.4% |
| 1 m1 month | +19.3% | +19.3% | - | +9.9% |
| 3 m3 months | -28.6% | -28.6% | - | -18.2% |
| 6 m6 months | -35.2% | -35.7% | - | -19.8% |
| ytdytd | +20.2% | +20.2% | - | +10.3% |
| 1 y1 year | -23.7% | -24.8% | +1.5% | -6.3% |
| 5 y5 years | -23.9% | -30.8% | +10.1% | +117.7% |
GALT Market Cap Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -3.1% | $82 M | +19.3% | |
| 3 m | 3-month | $151 M | -35.4% | $52 M | +86.8% |
| 6 m | 6-month | $193 M | -49.7% | $52 M | +86.8% |
| 1 y | 1-year | $262 M | -62.9% | $52 M | +86.8% |
| 3 y | 3-year | $262 M | -62.9% | $52 M | +86.8% |
| 5 y | 5-year | $292 M | -66.6% | $52 M | +86.8% |
| alltime | all time | $348 M | -72.1% | $2.88 M | +3281.5% |
Galectin Therapeutics Market Cap History
| Date | Value |
|---|---|
| 2025 | $97.28 M(+20.2%) |
| 2024 | $80.96 M(-21.1%) |
| 2023 | $102.68 M(+52.9%) |
| 2022 | $67.15 M(-45.3%) |
| 2021 | $122.84 M(-3.9%) |
| 2020 | $127.85 M(-21.4%) |
| 2019 | $162.72 M(+15.2%) |
| 2018 | $141.28 M(+18.2%) |
| 2017 | $119.54 M(+270.6%) |
| 2016 | $32.25 M(-31.8%) |
| 2015 | $47.27 M(-38.8%) |
| 2014 | $77.30 M(-48.0%) |
| Date | Value |
|---|---|
| 2013 | $148.57 M(+351.2%) |
| 2012 | $32.92 M(-55.8%) |
| 2011 | $74.42 M(+29.4%) |
| 2010 | $57.52 M(+297.0%) |
| 2009 | $14.49 M(+235.7%) |
| 2008 | $4.32 M(-84.7%) |
| 2007 | $28.26 M(+93.1%) |
| 2006 | $14.63 M(-82.4%) |
| 2005 | $83.31 M(+22.0%) |
| 2004 | $68.29 M(-28.2%) |
| 2003 | $95.11 M(+72.3%) |
| 2002 | $55.20 M |
FAQ
- What is Galectin Therapeutics market capitalization?
- What is the all time high market cap for Galectin Therapeutics?
- What is GALT market capitalization year-to-date change?
- What is Galectin Therapeutics market cap year-on-year change?
What is Galectin Therapeutics market capitalization?
The current market cap of GALT is $97.28 M
What is the all time high market cap for Galectin Therapeutics?
Galectin Therapeutics all-time high market capitalization is $348.29 M
What is GALT market capitalization year-to-date change?
Galectin Therapeutics market capitalization has changed by +$16.32 M (+20.16%) since the beginning of the year
What is Galectin Therapeutics market cap year-on-year change?
Over the past year, GALT market capitalization has changed by -$30.24 M (-23.71%)